Robust Glucose Control and Weight Loss after Six Weeks of Treatment with MEDI0382, a Balanced GLP-1/Glucagon Receptor Dual Agonist, in Patients with Type 2 Diabetes

被引：0
|
作者：
Ambery, Philip
Stumvoll, Michael W.
Posch, Maximilian G.
Heise, Tim
Plum-Moerschel, Leona
Tsai, Lan-Feng
Robertson, Darren
Petrone, Marcella
Rondinone, Cristina
Parker, Victoria E.
Hirshberg, Boaz
Jermutus, Lutz
机构：
来源：
DIABETES | 2018年 / 67卷
关键词：
D O I：
10.2337/db18-1067-P
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Dulaglutide, a GLP-1 receptor agonist, for the treatment of type 2 diabetes
    Clements, Jennifer
    Moore, Katherine
    Shealy, Kayce
    EXPERT REVIEW OF ENDOCRINOLOGY & METABOLISM, 2015, 10 (06) : 581 - 590
  • [32] Effect of tirzepatide, a dual GIP and GLP-1 receptor agonist, on glycaemic control and body weight in Japanese patients with type 2 diabetes
    Benson, C. T.
    Ohwaki, K.
    Furihata, K.
    Mimura, H.
    Oura, T.
    Imaoka, T.
    DIABETOLOGIA, 2019, 62 : S353 - S353
  • [33] Efpeglenatide Glucagon-like peptide 1 (GLP-1) receptor agonist Treatment for type 2 diabetes
    Reid, J.
    Rana, K.
    Segel, S. A.
    Sheikh-Ali, M.
    Choksi, R. R.
    Goldfaden, R. F.
    DRUGS OF THE FUTURE, 2019, 44 (06) : 435 - 441
  • [34] MEDI0382 a novel GLP1/glucagon co-agonist induces profound body weight loss and improves metabolism in rodents and non-human primates
    Konkar, A.
    Ambery, P.
    Bednarek, M.
    Fritsch-Fredin, M.
    Grimsby, J.
    Henderson, S.
    Hornigold, D.
    Jackson, R.
    Rondinone, C.
    Trevaskis, J.
    Jermutus, L.
    DIABETOLOGIA, 2015, 58 : S310 - S310
  • [35] LY3437943 (LY), a Novel Triple GIP/GLP-1/Glucagon Receptor Agonist, Provides Glucose Lowering and Weight Loss in Patients with T2DM after 12 Weeks of Treatment
    Urva, Shweta
    Loh, Mei Teng
    Coskun, Tamer
    Du, Yu
    Benson, Charles
    Loghin, Corina
    Haupt, Axel
    Milicevic, Zvonko
    DIABETES, 2022, 71
  • [36] Long-Acting GLP-1 and Glucagon Receptor Dual Agonists for the Treatment of Type 2 Diabetes
    You, Seohee
    Mcdonald, Mary
    Case, Martin
    Steiner, Derek
    Tat, Timothy
    Jenkinson, Celia
    Pick, Rebecca
    Hart, Juliet
    Moreno, Veronica
    Parise, Jason
    Yan, Wen
    Camacho, Raul
    Swanson, Ronald
    Chi, Ellen
    Demarest, Keith
    Leonard, James
    DIABETES, 2016, 65 : A274 - A274
  • [37] Obesity/Type 2 diabetes: GLP-1 agonist tirzepatide promotes weight loss
    Simon, Annika
    DIABETOLOGIE UND STOFFWECHSEL, 2024, 19 (01) : 27 - 28
  • [38] Obesity/Type 2 diabetes: GLP-1 agonist tirzepatide promotes weight loss
    Simon, Annika
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2024, 149 (08) : 416 - 416
  • [39] Influence of GLP-1 receptor agonist on insulin dosage and blood glucose control of patients with type 2 diabetes mellitus
    Shen, Yimei
    Yang, Xiaohua
    Han, Xiaojun
    Xi, Wei
    Jiang, Lihua
    Wang, Shuqin
    Zhong, Haifeng
    Gu, Yunjuan
    AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2021, 13 (10): : 11814 - 11823
  • [40] Exenatide.: Treatment of type 2 diabetes GLP-1 receptor agonist
    McIntyre, JA
    Bayés, M
    DRUGS OF THE FUTURE, 2004, 29 (01) : 23 - 31
12345